A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults

NCT06101173 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio)
BIOLOGICAL: Inactivated poliomyelitis vaccine (IPOL)
BIOLOGICAL: VLP-Polio
BIOLOGICAL: IPOL
BIOLOGICAL: VLP-Polio
BIOLOGICAL: IPOL

Sponsor

CanSino Biologics Inc.

Collaborators

[object Object]